Bioethics commissions create new regulatory frameworks for emerging threats – promotes consensus and norms
Wolf et al 2/28 -- Professor of Law, Medicine & Public Policy at the University of Minnesota, JD [Susan M., R. Alta Charo, JD, Alexander Morgan Capron, LLB, Rebecca Dresser, JD, MS, Helene D. Gayle, MD, MPH; Christine Grady, MSN, PhD; Marion Hourdequin, PhD; Isaac Kohane, MD, PhD. “Recommending a New Presidential Bioethics Commission.” National Academies of Science, Engineering, and Medicine. 2/28/2022.]
Need for a New Commission The United States has not had a federal bioethics commission since 2017. In the interceding five years, a global pandemic has raised profound ethical issues in public health research, clinical practice, and public policy–issues that require attention to the public good as well as individual autonomy. Those include how to formulate public policy in the face of uncertainty, how best to conduct rapid research on vaccines and treatments, how to reconcile population research with individual patient needs, how to allocate access to therapeutic interventions in times of scarcity, and how to address the devastating health disparities the pandemic has revealed. 3 As noted in Appendix A, the President’s Commission was followed by a failed effort to create a Biomedical Ethics Board in the legislative branch with six Senators and six Representatives equally divided between the two major parties. More specialized executive branch panels have included the Advisory Committee on Human Radiation Experiments (1994-95) established to investigate human radiation experiments and the intentional release of radiation between 1944 and 1974 and to recommend appropriate standards for evaluating the responsibility of individuals and institutions for those past acts. 4 The Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. https://braininitiative.nih.gov/. 3 At the same time, our world faces a climate crisis that imperils the natural environment and human health. No prior bioethics commission has canvassed the ethical issues raised by research and interventions that can alter ecology, including genetic modification of insect populations to control transmission of certain deadly diseases, or using genome editing to rescue endangered species and perhaps even to revive some that are extinct. Nor has any commission addressed the health and equity implications of heat waves and heat stress, changes in the distribution of vector-borne diseases, flooding and displacement, and increased ozone pollution, to mention just a few effects of climate change. Yet ethical concerns—including our obligations to future generations—are central to understanding and solving these environmental problems. Another domain not previously addressed by a bioethics commission is the growing integration of artificial intelligence (AI), machine learning, and software algorithms into medical and public health practice. The ethical challenges are profound. If complex algorithms are based on inadequate or unrepresentative data, their use risks magnifying and cementing racial and other bias into research and clinical care, while undermining professional expertise and shared decision-making with patients. Regulators face daunting challenges, such as ensuring the quality of adaptive algorithms that evolve as they are used. Ethical issues raised by AI in health care and public health call for exactly the kind of path-breaking analysis and consensus building that a bioethics commission can offer. A bioethics commission could also advance analyses of existing technologies whose rapid development continues to raise unresolved issues. Genetic and genomic technologies, for example, offer an expanding range of predictive and screening tools – including direct-to-consumer tests -- with continuing debate over appropriate uses and safeguards. The growing use of such tools risks placing undue emphasis on genetics to the exclusion of social determinants of health. Genetic testing is also being used in areas such as immigration and law enforcement, raising privacy issues distinct from those raised by uses in health care. Meanwhile, emerging technologies that can alter the genetic makeup of animals and human beings challenge current oversight systems to protect responsible innovation while preventing abuse.